Interactions on record — worth a quick check against your medications. Based on 1 of 2 ingredients. Check your meds →
Dietary supplement

CitraNatal DHA Gelatin Capsule Ingredients & Drug Interactions

by Mission Pharmacal CitraNatal

Capsule Category: Fat/fatty Acid
Most serious interaction: Moderate
The interaction bottom line Most serious interaction: Moderate

CitraNatal DHA Gelatin Capsule is a dietary supplement by Mission Pharmacal CitraNatal with 2 active ingredients. Its ingredients are commonly taken for vegan/vegetarian source of omega-3s (dha and epa), heart and triglyceride health, brain and eye support.Based on those ingredients, 375 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are 40% from Algal Oil. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of CitraNatal DHA Gelatin Capsule by Mission Pharmacal CitraNatal

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Full disclosure
Ingredient Transparency · database check
Full

Every active ingredient lists its own amount on the label.

Why this rating?
  • The label discloses an exact amount for 2 of its 2 active ingredients.
  • “Docosahexaenoic Acid” is listed as a grouped ingredient — the label gives one combined amount (250 mg) without saying how much of each component you get.

CitraNatal DHA Gelatin Capsule contains 2 active ingredients: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), supplied as 40% from algal oil. These are omega-3 fatty acids that support heart, brain, and eye health.

The capsule also contains inactive ingredients — high oleic sunflower oil, sunflower lecithin, rosemary extract, tocopherols, and ascorbyl palmitate — which serve as the carrier, emulsifier, preservatives, and antioxidants.

Does it work?

Moderate evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Moderate

Some clinical evidence supports this product's ingredients for its stated purpose, but it isn't conclusive.

Why this rating?
  • The label markets this product for: Prenatal vitamin and DHA supplement.
  • We looked for evidence on: Infant development, Prematurity, Preterm labor, Fetal development, Maternal nutrition, Pregnancy support.
  • The strongest evidence on file: Algal Oil is rated "Possibly Effective" for Preterm labor (Natural Medicines).
  • Also on file: Algal Oil is rated "Insufficient Reliable Evidence To Rate" for Retinopathy of prematurity, Prematurity, Infant development.

For preterm labor, algal oil is rated possibly effective based on available evidence. For fractures, cystic fibrosis, physical performance, and cognitive function, the evidence suggests it is possibly ineffective.

For nonalcoholic fatty liver disease (NAFLD), there isn't enough reliable evidence in the data we hold to establish whether it works or doesn't.

The evidence, ingredient by ingredient Algal Oil

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 1 of the 1 matched ingredient.
  • Pregnancy & breastfeeding safety ratings cover 1 of 1.
  • General safety write-ups exist for 1 of 1.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Algal oil is generally well tolerated by most healthy adults at typical supplement doses. During pregnancy, DHA is often recommended, but use only under guidance of your healthcare provider.

During breastfeeding, DHA supports infant development, but talk to your provider before using this product. The product may theoretically increase low-density lipoprotein (LDL) cholesterol levels by about 8% in some people, and rare adverse effects such as hair loss, itching, rash, or warmth in the hands have been reported in individual cases, though causality is not always clear.

Side effects, ingredient by ingredient Algal Oil

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 1 of the 1 matched ingredient can interact with medications — Algal Oil.
  • The most serious interaction on file is rated Moderate.
  • Some involve high-stakes drug classes: anticoagulant / antiplatelet drugs; diabetes medications.
  • For scale: 375 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Before taking CitraNatal DHA, double-check any antihypertensive drugs (blood pressure medications) — algal oil may increase the risk of low blood pressure. Also check antidiabetes drugs, as algal oil may theoretically reduce their effects.

If you take anticoagulant or antiplatelet drugs (blood thinners), be aware of a minor bleeding-risk interaction, especially at higher doses.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFully disclosed formula with some supporting evidence for its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.

This supplement is intended to provide omega-3 fatty acids, particularly DHA, which is recommended in pregnancy and supports infant development. If you take blood pressure medications, diabetes medications, or blood thinners, check with your pharmacist before starting — this product may affect how they work.

Talk to your healthcare provider about whether it's right for you, especially during pregnancy or breastfeeding.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 1 of 2 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated May 22, 2015.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about CitraNatal DHA Gelatin Capsule, straight from the product label.

Brand Mission Pharmacal CitraNatal
Barcode (UPC) 689076898307
Net contents 6 Blister Pack(s)
Market status On market
Date entered into DSLD May 22, 2015
DSLD ID 45465
Product type Fat/fatty Acid
Supplement form Capsule
Dietary claims / uses Nutrient, All Other
Intended target group(s) Pregnant Women, Adult Female (18 - 50 Years), Lactating, Gluten Free
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for CitraNatal DHA Gelatin Capsule by Mission Pharmacal CitraNatal, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Pregnant and Lactating
Minimum serving Sizes:
1 Gelatin Capsule(s)
Maximum serving Sizes:
1 Gelatin Capsule(s)
UPC/BARCODE
689076898307
IngredientAmount% DV
Eicosapentaenoic Acid0.65 mg--
Docosahexaenoic Acid250 mg--
40% from Algal Oil625 mg--

Other ingredients: high Oleic Sunflower Oil, Sunflower Lecithin, Rosemary extract, Tocopherols, Ascorbyl Palmitate

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements

HOW SUPPLIED: Six child-resistant blister packs of 5 tablets and 5 capsules each - NDC 0178-0829-30

March of Dimes does not endorse specific products or brands.

Child-Resistant Blister Packaging

N

#1 RX prenatal vitamin brand

Rx Only

NDC 0178-0898-30

CONTAINS Six 5-day Blister Packs

The essential fatty acid DHA capsule is caramel colored and contains a light yellow to orange semi-solid mixture.

Gentle nutrition for baby and mom

General

500238 C01 Rev 011110

Seals/Symbols

Mission PHARMACAL(R)

life'sDHA(TM) HEALTHY BRAIN, EYES, HEART

march of dimes(R)

Brand IP Statement(s)

Copyright(C) 2011 Mission Pharmacal Company. All rights reserved.

lef'sDHA is a trademark of DSM. U.S. Patent No. 7,579,174 U.S. Patent No. 7,732,170 U.S. Patent No. 5,518,918

March of Dimes is a registered trademark of the March of Dimes Foundation.

Mission Pharmacal is a proud supporter of the March of Dimes(R).

Formula

Rx Prenatal Vitamin Tablet and 250 mg DHA Capsule

- Natural, plant-based DHA for your baby's healthy development

An Rx prenatal vitamin and omega-3 (DHA) derived from an all natural plant source

DESCRIPTION: CitraNatal(R) DHA is a prescription prenatal/postnatal multivitamin/mineral tablet with Ferr-Ease(R), a patented dual-iron delivery comprising both a quick release and slow release iron, and a capsule of an essential fatty acid.

INDICATIONS: CitraNatal(R) DHA is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and non-lactating mothers.

Formulation

- Gluten and lactose free

Precautions

CONTRAINDICATIONS: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING: Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.

Suggested/Recommended/Usage/Directions

DOSAGE AND ADMINISTRATION: One tablet and one capsule daily or as directed by a physician.

Storage

STORAGE: Store at 20-25(0)C (68-77(0)F)

See for yourself

CitraNatal DHA Gelatin Capsule by Mission Pharmacal CitraNatal label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in CitraNatal DHA Gelatin Capsule by Mission Pharmacal CitraNatal

These are the 2 active ingredients this product is made of. Select any to open its full monograph.

Serving size1 Gelatin Capsule(s) Dosage formCapsule Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Eicosapentaenoic Acid

0.65 mg per serving

Docosahexaenoic Acid

250 mg per serving

Other (inactive) ingredients: High Oleic Sunflower Oil, Sunflower Lecithin, Rosemary extract, Tocopherols, Ascorbyl Palmitate. These complete the product’s ingredient list but are not active constituents.

Interaction report

CitraNatal DHA Gelatin Capsule by Mission Pharmacal CitraNatal Drug Interactions

Want to check YOUR meds against CitraNatal DHA Gelatin Capsule?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
375Drugs
258 Moderate 117 Minor

Ingredients driving the most interactions

Each ingredient & the kinds of drugs it affects

For each ingredient in CitraNatal DHA Gelatin Capsule with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.

40% from Algal Oil3 drug types · 375 drugs

Antidiabetes Drugs

Theoretically, taking algal oil with antidiabetes drugs might interfere with the effects of antidiabetes drugs and reduce their effects.
Most algal oil contains docosahexaenoic acid (DHA). Clinical research in people with type 2 diabetes, including those taking antidiabetes drugs, shows that taking DHA 4 grams daily for 6 weeks increases fasting blood glucose levels by about 18 mg/dL when compared with taking olive oil.

Likelihood Possible Evidence D
Antihypertensive Drugs

Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Algal oil usually contains docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA). There is evidence that fish oil, which also contains DHA and EPA, can modestly lower blood pressure and might have additive effects in patients treated with antihypertensive drugs.

Likelihood Possible Evidence D
Anticoagulant/Antiplatelet Drugs

Theoretically, algal oil may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
The risk of interaction is highest for algal oil containing high amounts (> 2 grams daily) of eicosapentaenoic acid (EPA), or EPA and docosahexaenoic acid (DHA). High doses of EPA or oils containing EPA and DHA can reduce platelet aggregation in humans. However, most algal oil contains very little EPA and larger amounts of DHA. While some conflicting evidence exist, most research shows that DHA alone does not affect blood clotting.

Likelihood Unlikely Evidence D
The maker

Brand information

Manufacturer and brand details for CitraNatal DHA Gelatin Capsule, from the product label.

Mission Pharmacal CitraNatal

See all Mission Pharmacal CitraNatal products
Phone Number
(210) 696-8400
Pharmacist Counseling Corner

CitraNatal DHA Gelatin Capsule by Mission Pharmacal CitraNatal: Common Questions

Does CitraNatal DHA Gelatin Capsule by Mission Pharmacal CitraNatal interact with any medications?
Yes. Based on its ingredients, CitraNatal DHA Gelatin Capsule has a known interaction with 375 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
CitraNatal DHA Gelatin Capsule contains 2 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Can I take this during pregnancy?
DHA is often recommended in pregnancy and is rated likely safe. However, use only under the guidance of your healthcare provider, who can advise you based on your individual needs and any other medications you take.
Is this safe while breastfeeding?
DHA supports infant development, which is why it's discussed in breastfeeding contexts. Talk to your healthcare provider or pharmacist before using this product while nursing — they can give you personalized advice.
What are EPA and DHA, and why are they in this supplement?
EPA and DHA are omega-3 fatty acids found in algal oil. They support heart, brain, and eye health, which is why they're common in prenatal and general wellness supplements.
Does this supplement help with brain and eye development?
The evidence we hold shows mixed results. For cognitive function, the data suggests it is possibly ineffective. DHA is often marketed for brain and eye support in pregnancy and infant health, but effectiveness ratings in our data do not support a strong claim for cognitive benefits.
Can this raise my cholesterol?
Yes. Algal oil containing DHA may modestly increase low-density lipoprotein (LDL) cholesterol by about 8% in people without existing heart disease. If you have cholesterol concerns, talk to your doctor before starting.
Why does the product say 40% from algal oil?
That means the DHA and EPA in the capsule come from algal oil at a 40% concentration — the rest of the capsule is the carrier oil and other inactive ingredients that help deliver and preserve the omega-3s.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if CitraNatal DHA Gelatin Capsule is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

CitraNatal DHA Gelatin Capsule label
Go deeper

The Full Monographs Behind CitraNatal DHA Gelatin Capsule’s Ingredients

Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.

Sources

Sources & How We Checked

CitraNatal DHA Gelatin Capsule's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 43 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Algal Oil 43 references
  1. Prisco D, Paniccia R, Bandinelli B, et al. Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients. Thromb Res 1998;1:105-12.
  2. Grimsgaard S, Bonaa KH, Hansen JB, Nordoy A. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr 1997;66:649-59.
  3. Toft I, Bonaa KH, Ingebretsen OC, et al. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. Ann Intern Med 1995;123:911-8.
  4. Sacks FM, Hebert P, Appel LJ, et al. Short report: the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the trials of hypertension prevention. J Hypertens 1994;12:209-13.
  5. Vandongen R, Mori TA, Burke V, et al. Effects on blood pressure of omega 3 fats in subjects at increased risk of cardiovascular disease. Hypertension 1993;22:371-9. PubMed
  6. FDA. Center for Food Safety and Applied Nutrition. Letter regarding dietary supplement health claim for omega-3 fatty acids and coronary heart disease. Available at: http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-Rpt0272-38-Appendix-D-Reference
  7. Leaf A. On the reanalysis of the GISSI-Prevenzione. Circulation 2002;105:1874-5. PubMed
  8. Connor WE. n-3 Fatty acids from fish and fish oil: panacea or nostrum? Am J Clin Nutr 2001;74;415-6. PubMed
  9. Calder PC. N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale? Nutr Res 2001;21:309-41. DOI
  10. Pedersen HS, Mulvad G, Seidelin KN, et al. N-3 fatty acids as a risk factor for haemorrhagic stroke. Lancet 1999;353:812-3. PubMed
  11. Terano T, Hirai A, Hamazaki T, et al. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis 1983;46:321-31.. PubMed
  12. Kris-Ehterton PM, Harris WS, Appel LJ, et al. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-57. PubMed
  13. Woodman RJ, Mori TA, Burke V, et al. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002;76:1007-15.. PubMed
  14. Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003;160:996-8.. PubMed
  15. Leng GC, Smith FB, Fowkes FG, et al. Relationship between plasma essential fatty acids and smoking, serum lipids, blood pressure and haemostatic and rheological factors. Prostaglandins Leukot Essent Fatty Acids 1994;51:101-8. PubMed
  16. Nelson GJ, Schmidt PS, Bartolini GL, et al. The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 1997;32:1129-36. PubMed
  17. Wheaton DH, Hoffman DR, Locke KG, et al. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa. Arch Ophthalmol 2003;121:1269-78. PubMed
  18. Svaneborg N, Kristensen SD, Hansen LM, et al. The acute and short-time effect of supplementation with the combination of n-3 fatty acids and acetylsalicylic acid on platelet function and plasma lipids. Thromb Res 2002;105:311-6. PubMed
  19. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369:1090-8. PubMed
  20. von Houwelingen R, Nordøy A, van der Beek E, et al. Effect of a moderate fish intake on blood pressure, bleeding time, hematology, and clinical chemistry in healthy males. Am J Clin Nutr. 1987 Sep;46(3):424-36. PubMed
  21. Goodnight SH Jr, Harris WS, Connor WE. The effects of dietary omega 3 fatty acids on platelet composition and function in man: a prospective, controlled study. Blood. 1981 Nov;58(5):880-5. DOI
  22. Mori, T. A., Bao, D. Q., Burke, V., Puddey, I. B., and Beilin, L. J. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 1999;34(2):253-260. PubMed
  23. Nestel, P., Shige, H., Pomeroy, S., Cehun, M., Abbey, M., and Raederstorff, D. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am.J.Clin.Nutr. 2002;76(2):326-330. PubMed
  24. Woodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Barden, A., Watts, G. F., and Beilin, L. J. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients PubMed
  25. Theobald, H. E., Goodall, A. H., Sattar, N., Talbot, D. C., Chowienczyk, P. J., and Sanders, T. A. Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. J Nutr 2007;137(4):973-978.
  26. Mischoulon D, Best-Popescu C, Laposata M, et al. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol. 2008;18(9):639-645. PubMed
  27. Arterburn, L. M., Oken, H. A., Bailey, Hall E., Hamersley, J., Kuratko, C. N., and Hoffman, J. P. Algal-oil capsules and cooked salmon: nutritionally equivalent sources of docosahexaenoic acid. J Am Diet Assoc 2008;108(7):1204-1209. PubMed
  28. Zucker, M. L., Bilyeu, D. S., Helmkamp, G. M., Harris, W. S., and Dujovne, C. A. Effects of dietary fish oil on platelet function and plasma lipids in hyperlipoproteinemic and normal subjects. Atherosclerosis 1988;73(1):13-22. PubMed
  29. Bernstein AM, Ding EL, Willett WC, Rimm EB. A meta-analysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease. J Nutr. 2012;142(1):99-104.
  30. Carlson SE, Colombo J, Gajewski BJ, Gustafson KM, Mundy D, Yeast J, Georgieff MK, Markley LA, Kerling EH, Shaddy DJ. DHA supplementation and pregnancy outcomes. Am J Clin Nutr. 2013 Apr;97(4):808-15. PubMed
  31. Fu YQ, Zheng JS, Yang B, Li D. Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. J Epidemiol. 2015;25(4):261-74. PubMed
  32. Imhoff-Kunsch B, Stein AD, Villalpando S, Martorell R, Ramakrishnan U. Docosahexaenoic acid supplementation from mid-pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. J Nutr. 2011 Feb;141(2): PubMed
  33. Mulder KA, King DJ, Innis SM. Omega-3 fatty acid deficiency in infants before birth identified using a randomized trial of maternal DHA supplementation in pregnancy. PLoS One. 2014 Jan 10;9(1):e83764. PubMed
  34. Richardson AJ, Burton JR, Sewell RP, Spreckelsen TF, Montgomery P. Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: a randomized, controlled trial (the DOLAB Study). PLoS One. 2012;7(9):e43909. PubMed
  35. Ballantyne CM, Bays HE, Kastelein JJ, Stein E, Isaacsohn JL, Braeckman RA, Soni PN. Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study). Am J Cardi PubMed
  36. FDA announces qualified health claims for omega-3 fatty acids. Available at: https://www.fda.gov/Food/LabelingNutrition/ucm072756.htm. Accessed April 15 2019.
  37. Breastfeeding and the use of human milk. Section on Breastfeeding. Pediatrics. 2012;129(3):e827-41. PubMed
  38. Zhang Z, Fulgoni VL, Kris-Etherton PM, Mitmesser SH. Dietary Intakes of EPA and DHA Omega-3 Fatty Acids among US Childbearing-Age and Pregnant Women: An Analysis of NHANES 2001-2014. Nutrients. 2018;10(4). PubMed
  39. Montgomery P, Spreckelsen TF, Burton A, Burton JR, Richardson AJ. Docosahexaenoic acid for reading, working memory and behavior in UK children aged 7-9: A randomized controlled trial for replication (the DOLAB II study). PLoS One. 2018;13(2):e0192909. PubMed
  40. Rao A, Briskey D, Nalley JO, Ganuza E. Omega-3 eicosapentaenoic acid (EPA) rich extract from the microalga Nannochloropsis decreases cholesterol in healthy individuals: A double-blind, randomized, placebo-controlled, three-month supplementation study. Nut PubMed
  41. Marc I, Piedboeuf B, Lacaze-Masmonteil T, et al. Effect of maternal docosahexaenoic acid supplementation on bronchopulmonary dysplasia-free survival in breastfed preterm infants: A randomized clinical trial. JAMA. 2020;324(2):157-167. PubMed
  42. Fougère H, Bilodeau JF, Lavoie PM, et al. Docosahexaenoic acid-rich algae oil supplementation on breast milk fatty acid profile of mothers who delivered prematurely: a randomized clinical trial. Sci Rep 2021;11(1):21492. PubMed
  43. Yang Y, Li G, Li F, et al. Impact of DHA from algal oil on the breast milk DHA levels of lactating women: A randomized controlled trial in China. Nutrients 2022;14(16):3410. PubMed

See these in context on the Algal Oil monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring